AU2010209650(A1)KeyintermediatesforthesynthesisofRosuvastatinorpharmaceuticallyacceptablesaltsthereof.Inventor(s):ZDENKOCASARJANEZKOSMRLJ(CASAR,ZDENKO,KOSMRLJ,JANEZ)Applicant(s):LEKPHARMACEUTICALS(LEKPHARMACEUTICALSD.D)Classification:-international:A61K31/505A61P3/06C07D239/42-European:C07D239/42从上述信息判断该文献的文献类型为：
举一反三
- AU2010209650 (A1) Key intermediates for the synthesis of Rosuvastatin or pharmaceutically acceptable salts thereof . Inventor(s): ZDENKO CASAR; JANEZ KOSMRLJ + (CASAR, ZDENKO, ; KOSMRLJ, JANEZ) Applicant(s): LEK PHARMACEUTICALS + (LEK PHARMACEUTICALS D.D) Classification: - international: A61K31/505; A61P3/06; C07D239/42 - European: C07D239/42 从上述信息判断该文献的文献类型为：
- AU2010209650 (A1) Key intermediates for the synthesis of Rosuvastatin or pharmaceutically acceptable salts thereof . Inventor(s): ZDENKO CASAR JANEZ KOSMRLJ (CASAR, ZDENKO, KOSMRLJ, JANEZ) Applicant(s): LEK PHARMACEUTICALS (LEK PHARMACEUTICALS D.D) Classification: - international: A61K31/505 A61P3/06 C07D239/42 - European: C07D239/42 从上述信息判断该文献的文献类型为：
- 中国大学MOOC: AU2010209650 (A1) Key intermediates for the synthesis of Rosuvastatin or pharmaceutically acceptable salts thereof . Inventor(s): ZDENKO CASAR; JANEZ KOSMRLJ + (CASAR, ZDENKO, ; KOSMRLJ, JANEZ) Applicant(s): LEK PHARMACEUTICALS + (LEK PHARMACEUTICALS D.D) Classification: - international: A61K31/505; A61P3/06; C07D239/42 - European: C07D239/42 从上述信息判断该文献的文献类型为：
- AU2010209650 (A1) Key intermed...42 从上述信息判断该文献的文献类型为：
- 17e43d27acb96b6.jpg竖直度盘读数为： A: 107°61′42″ B: 108°01′42″ C: 61°35′36″ D: 61°44′30″